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Abstract
Purpose To investigate the inter-reader agreement in assessing high-resolution computed tomography (HRCT) features of 
coronavirus disease 2019 (COVID-19) pneumonia.
Method Seventy-seven consecutive patients (mean age, 64 ± 15 years) with mild COVID-19 pneumonia that underwent 
HRCT were retrospectively included. Three radiologists [two devoted to thoracic imaging (R1, R2), and one generalist (R3)] 
on a per-examination basis independently assessed ground-glass opacity (GGO), consolidation, and crazy-paving pattern. 
The extent of each feature (total feature score, TFS) was semi-quantitatively assessed, and each TFS summed up to obtain 
total lung score (TLS). Presence of organizing pneumonia (OP) pattern was also recorded. The inter-reader agreement was 
calculated with Cohen’s Kappa (k) and Free-Marginal Multirater k. Multivariable analysis was run to determine whether 
imaging features were predictive of short-term evolution to severe disease (need for ventilation).
Results Most features showed substantial inter-reader agreement, including TLS > 6 (k = 0.69), which was an independent 
predictor of short-term occurrence of severe disease, regardless of the reader (OR 9–53.19). Consolidation TFS > 2 and OP 
pattern showed substantial and moderate agreement, respectively, only when comparing R1 and R2. Consolidation TFS > 2 
and OP pattern were independent predictors of severe disease for R2 (OR 4.87) and R1 (OR 6), respectively.
Conclusions The inter-reader agreement for most HRCT features of COVID-19 pneumonia ranges moderate-to-substantial, 
though it depends on readers’ experience in the case of consolidation and OP pattern.
Keywords High-resolution computed tomography · Pneumonia · Coronavirus · Inter-reader agreement
Introduction
Lung disease is the main manifestation of the COVID-19 
[1], with clinical presentation ranging from asymptomatic 
to fever, dry cough, fatigue, and dyspnea, up to respiratory 
failure in severe cases [2]. The standard of reference for 
diagnosis is the reverse transcriptase polymerase chain reac-
tion (RT-PCR) test, using nasal-pharyngeal swabs or lower 
respiratory tract specimens [3].
Chest HRCT plays an important role in the detection of 
COVID-19 pneumonia, with reported sensitivity ranging 
from 61% [4] to 99% in a study performed in a setting with 
high disease prevalence [5]. Typical findings include GGO 
and consolidation, involving multiple lobes of both lungs 
[6], as well as OP pattern [7]. Despite the low specificity 
(about 25–33%) [8, 9], HRCT with typical appearance may 
be of help when there is diagnostic uncertainty in a patient 
with high pretest probability for the disease [6]. In this light, 
an expert consensus statement from the Radiological Society 
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of North America (RSNA) provided a system for categoriz-
ing HRCT findings based on the likelihood they represent 
COVID-19 pneumonia [7].
Another target of research is as to whether HRCT can 
predict unfavorable clinical outcome, which has been vari-
ably defined as progression to severe disease, Intensive Care 
Unit (ICU) admission, or death [10–13]. Previous Authors 
[10–13] found that qualitative and semi-quantitative indexes 
expressing the amount of lung involvement are associated 
to disease worsening.
One might assume that the pre-requisite for using HRCT 
as a diagnostic and predictive tool is adequate inter-reader 
agreement in assessing COVID-19 pneumonia-related 
HRCT features. To our knowledge, a few studies only inves-
tigated this topic [14–17]. Thus, it is uncertain whether 
interpretation and quantification of lung involvement can be 
reliably provided across different readers and different geo-
graphical areas involved by the pandemic [18]. Moreover, 
an adequate inter-reader agreement may further support the 
use of HRCT in many COVID-19 related clinical situations, 
e.g., in case of swab/clinical data doubts, in the evolution/
worsening of the disease, and in the outcome evaluation.
The aim of the study was to investigate the inter-reader 




The Ethical Committee approved the study protocol, and 
waived for the acquisition of the informed consent, given 
the retrospective design.
By performing a search in the database of our COVID-
19-center, we identified all the consecutive adult patients 
with suspected COVID-19 pneumonia who underwent chest 
HRCT examination in the period March-April 2020. Before 
HRCT, all patients performed RT-PCR test for severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasal-
pharyngeal swabs, and were categorized according to the 
Italian Society of Emergency Medicine (SIMEU) classifi-
cation of clinical phenotypes [19]. The latter included: (i) 
phenotype 1: fever without respiratory failure and normal 
chest X-ray; (ii) phenotype 2: fever with chest X-ray and 
arterial blood gas test indicating lung focus and/or mild res-
piratory failure [partial pressure of arterial blood oxygen 
(PaO2) > 60 mmHg]; (iii) phenotype 3: fever with moderate-
severe respiratory failure (PaO2 < 60 mmHg in room air); 
(iv) phenotype 4: respiratory failure with suspected initial 
acute respiratory distress syndrome (ARDS) or complicated 
pneumonia; and (v) phenotype 5: overt ARDS [18]. Oxygen 
therapy and/or continuous positive airway pressure (CPAP) 
ventilation were indicated in patients with SIMEU pheno-
types 3–4 pneumonia, while orotracheal intubation with 
invasive ventilation was the treatment for SIMEU pheno-
types 4–5 [19].
Of the 192 eligible subjects, we excluded 104 patients 
with negative RT-PCR test, and 11 patients with clinical 
phenotypes 3–5 at the time of HRCT. Therefore, the final 
population consisted of 77 patients (40 men and 37 women, 
mean age 64 ± 15 years) with mild COVID-19 pneumonia 
(i.e., SIMEU clinical phenotypes 1–2). In cases the patient 
had undergone several HRCT examinations, only the base-
line one was included in the analysis.
HRCT examinations
HRCTs were performed on a 64-row Computed Tomography 
(CT) scanner (LightSpeed, General Electric, Milwaukee, 
Wisconsin, USA), by means of volumetric acquisition with 
the patient in the supine position, at suspended full inspira-
tion. Image acquisition parameters were as follows: 0.6 s 
gantry revolution time, 100–350 mA tube current modula-
tion range, 120 kV tube potential, 64 mm × 0.625 mm detec-
tor configuration, 1.25 mm reconstructed section thickness 
and interval. In 4/77 patients (5.2%) iodinated contrast 
medium [iomeprol 350 mgI/mL (Iomeron, Bracco Imaging, 
Milan, Italy)] was intravenously injected before scanning. 
Two image sets were reconstructed and displayed, including 
one with high-spatial-frequency algorithm and pulmonary 
parenchyma windowing (level, −500 HU; width, 1700 HU), 
and the other with soft tissue algorithm and windowing 
(level, 50 HU; width, 350 HU).
Image analysis
For each patient, three readers recorded the presence of 
GGO, consolidation, and crazy-paving pattern, as defined by 
the glossary of terms for thoracic imaging from Fleischner 
Society [20]. Readers included two radiologists devoted to 
thoracic imaging, namely reader 1 (R1) and reader 2 (R2), 
with 10 and 3 years of experience, respectively, and one 
generalist radiologist (R3) with 20 years of experience in 
body imaging. Readers also assessed whether GGO and/or 
consolidation presented with an OP pattern, i.e., whether 
they showed triangular or polygonal shape, or were associ-
ated with perilobular pattern, bronchial dilatation, reverse 
halo sign, linear and band-like opacities, and signs of fibrosis 
[21]. On a per-examination basis, six lung zones were identi-
fied (3 per lung), i.e., two upper zones (above the carina), 
two middle zones (from the carina to the inferior pulmonary 
veins), and two lower zones (below the inferior pulmonary 
veins). Readers then assessed the zonal extent of GGO, 
consolidation, and crazy-paving pattern, using a previously 
reported semi-quantitative score [11, 22]. Score was 0 if 
La radiologia medica 
1 3
the feature was not present, 1 if it was present with a <25% 
zonal involvement, 2 for a ≥25% to <50% involvement, 3 
for a ≥50% to <75% involvement, and 4 for ≥75% involve-
ment. Therefore, the per-patient total score for each pulmo-
nary feature (TFS) ranged from 0 (i.e., a certain feature was 
scored 0 in each of the six lung zones) to 24 (i.e., a certain 
feature was scored 4 in each of the six lung zones). TLS was 
defined as the summing up of the GGO, consolidation, and 
crazy-paving pattern TFSs.
Clinical data analysis
For all patients, comorbidities and time from symptoms 
onset to HRCT examination were reported. We recorded the 
patients’ SIMEU phenotype twice, i.e., the one observed at 
the time of HRCT examination, and the worst one noticed 
in the 15-day period following HRCT. For the purpose of 
analysis, SIMEU phenotypes recorded during the follow-up 
period were dichotomized into mild disease group [includ-
ing patients with no or mild respiratory failure (SIMEU 
phenotype 1 or 2)] versus severe disease group [includ-
ing patients with moderate-to-severe respiratory failure or 
ARDS (SIMEU phenotype 3–5)].
On this basis, the study outcome was defined as the devel-
opment of severe disease in the 15-day period following 
HRCT, i.e., a shift from SIMEU phenotype 1–2 to SIMEU 
phenotype 3–5.
Statistical analysis
We used descriptive statistics to summarize HRCT find-
ings, and coupled relevant proportions with 95% confi-
dence intervals (95%CI). After checking whether continu-
ous data showed normal distribution, we described them as 
means ± standard deviation or medians with the interquartile 
range (IQR). The Cochran’s Q test was used to determine 
whether there was any significant difference in the preva-
lence of each HRCT feature among the three sets of read-
ings. Pairwise comparisons were performed with the McNe-
mar test.
To determine the inter-reader agreement in assessing 
HRCT features we used Percent Agreement (PA), Cohen’s 
Kappa (k), as recommended by the Guidelines for Report-
ing Reliability and Agreement Studies (GRRAS) [23], as 
well as Free-Marginal Multirater k. We used a TFS cut-
off of >2, and a TLS cut-off >6 for including data into the 
analysis. When paradox k was observed [i.e., unacceptable 
kappa value (k ≤ 0.41) and acceptable percent agreement 
(PA ≥ 0.80) with Prevalence Index and Bias Index differ-
ent from zero], the imbalance was corrected by using the 
prevalence-adjusted bias-adjusted kappa (PABAK) statistic 
[24, 25]. Interpretation of k and PABAK coefficient was 
as follow: <0.00, poor; 0.00–0.20, slight; 0.21–0.40, fair; 
0.41–0.60, moderate; 0.61–0.80, substantial; 0.81–1.00, 
almost perfect [26].
On a per-reader basis, we then performed a logistic 
regression analysis with the stepwise approach to assess 
whether HRCT presentation could predict the occurrence 
of the study outcome as defined above. The model included 
TLS > 6, consolidation > 2, crazy-paving pattern > 2, and 
presence of OP pattern. Preliminary univariable analysis 
was performed with the chi-square test.
Analyses were performed using MedCalc statistical soft-
ware (MedCalc Software bvba, version 18.11.6, Ostend, 
Belgium), and Online Kappa Calculator (Computer Soft-
ware, retrieved from http://justu s.rando lph.name/kappa ). 
The reference alpha value was 0.05. When appropri-
ate, the Bonferroni correction was used (0.05/3 pairwise 
comparisons = 0.017).
Results
Study population and HRCT findings
Patients showed at least one comorbidity in 57% (44/77) of 
cases, and ≥2 comorbidities in 26% (20/77) of cases, respec-
tively. Cardiovascular, oncological, and respiratory dis-
eases were the most frequent ones, reported in 42% (32/77), 
13% (10/77), and 12% (9/77) of patients, respectively. The 
median time period from the onset of symptoms to HRCT 
was 5 days (IQR, 2–9 days). 38 over 77 patients (49%) devel-
oped severe disease during the 15-day period following the 
HRCT examination [median (IQR) time 1 (1, 2) day].
The per-reader distribution of HRCT findings is shown 
in Table 1. Regardless of the reader, the most frequent fea-
tures were GGO > 2 (74–83% of patients) and OP pattern 
(38–68% of patients), while a TLS > 6 was found in 65–69% 
of patients. Overall, the prevalence of HRCT features was 
not significantly different among readers, except for OP pat-
tern, which was more frequently reported by R1 than R3 
(52/77 versus 29/77 patients, p < 0.001), and by R2 than R3 
(43/77 versus 29/77 patients, p = 0.014). Example cases are 
shown in Figs. 1 and 2.
Inter‑reader agreement in assessing HRCT features
Table 2 shows the results of the inter-reader agreement 
analysis. When comparing the three radiologists at the same 
time, we found that they agreed to a substantial extent in 
assessing HCRT features (k values ranging 0.65–0.74). The 
highest agreement was observed in the case of GGO > 2 
(k = 0.74) and TLS > 6 (k = 0.69). Exceptions were consoli-
dation and OP pattern, for which the agreement was moder-
ate (k = 0.60) and fair (k = 0.32), respectively.
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When comparing the radiologists on a pairwise basis, 
the agreement was moderate to substantial for most HRCT 
features. The only exception was the OP pattern, which 
was scored with moderate agreement by R1 versus R2, fair 
agreement by R1 versus R3, and fair agreement by R2 versus 
R3. Of note, the inter-reader agreement between more expe-
rienced readers (R1 and R2) was substantial for consolida-
tion and moderate for OP pattern.
Table 1  Per-reader distribution of HRCT findings (n = 77). The 
“difference in prevalence” columns report the p values expressing 
whether the prevalence of the detected HRCT features was signifi-
cantly different among the three readers and on a pairwise basis (R1 
versus R2, R1 versus R3, R2 versus R3)
a Cochran’s Q test
b McNemar test; HRCT, high-resolution computed tomography; 95%CI, 95% confidence interval; R1, reader 1; R2, reader 2; R3, reader 3; R, 
reader; TLS, total lung score; GGO, ground-glass opacity; OP, organizing pneumonia
Numbers in bold refer to R1, R2, and R3. Numbers in italic refer to p values when statistically significant
HRCT feature Prevalence of detection
n (%, 95%CI)
Difference in prevalence




TLS > 6 50 (65, 48–86) 52 (68, 50–89) 53 (69, 52–90) 0.678 2 0.774
3 0.549 1.000
GGO > 2 57 (74, 56–96) 63 (82, 63–100) 64 (83, 64–100) 0.057 2 0.146
3 0.092 1.000
Consolidation > 2 25 (32, 21–48) 16 (21, 12–34) 22 (29, 18–43) 0.065 2 0.012
3 0.648 0.210
Crazy-paving pattern > 2 15 (19, 11–32) 13 (17, 9–29) 8 (10, 4–20) 0.142 2 0.791
3 0.119 0.227
OP pattern 52 (68, 50–89) 43 (56, 40–75) 29 (38, 25–54) <0.001 2 0.035
3 <0.001 0.014
Fig. 1  48-year old man with 
confirmed COVID-19 pneu-
monia. At hospital admission, 
HRCT images on axial (a) 
and coronal (b) planes showed 
bilateral, mostly peripheral 
GGO and consolidations. The 
two horizontal white lines in 
(b) delimit the upper, middle, 
and lower lung zones, which 
were identified to apply the 
semi-quantitative score (see the 
text for details). The scheme 
in (c) resumes how each of the 
three readers (R1, R2, and R3) 
assigned the TFS for GGO, 
consolidation, and crazy-paving 
pattern, thus allowing the cal-
culation of TLS as the sum of 
all the TFSs. For all the readers, 
TLS was >6, a feature we found 
to be predictive for short-term 
occurrence of severe disease. 
After one day, the patient devel-
oped respiratory failure [Italian 
Society of Emergency Medicine 
(SIMEU) phenotype III disease]
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Online Resource 1 shows the PA values we used to verify 
whether the prerequisites for using PABAK were matched 
(or not), as described above. PA values do not represent pri-
mary measurements of agreement, as they do not account 
for the effect of chance.
Prediction of unfavorable outcome
Table 3 shows the results of univariable analysis and multi-
variable analysis, including a model built upon each reader. 
On multivariable analysis, independent predictors of severe 
disease were TLS > 6 (for all readers), OP pattern (for R1) 
and consolidation > 2 (for R2).
Discussion
Chest HRCT represents a valuable imaging tool both in 
diagnosis and management of patients with COVID-19 
[27], through suggesting a possible diagnosis of COVID-
19 in a high suspicion clinical setting and indicating a 
progression in disease severity at follow-up (e.g., signs of 
disease progression such as consolidation or crazy-paving 
pattern, or bacterial superinfection) [28]. In this study, the 
agreement in assessing HRCT features of mild COVID-19 
pneumonia among the three readers with different experi-
ence in thoracic imaging was fair in the case of OP pattern, 
moderate in the case of consolidation > 2, and substantial 
Fig. 2  61-year old woman 
with confirmed COVID-19 
pneumonia. At hospital admis-
sion, HRCT images on axial (a) 
and sagittal (b) planes showed 
bilateral, peripheral GGO)and 
band-like opacities with a peri-
lobular distribution, resembling 
an OP pattern. OP pattern was 
deemed present by all readers. 
After 5 days, the patient devel-
oped respiratory failure [Italian 
Society of Emergency Medicine 
(SIMEU) phenotype IV disease]
Table 2  Inter-reader agreement 
in assessing HRCT features. 
The “inter-reader agreement” 
columns express the magnitude 
of the agreement in assessing 
a certain HRCT feature among 
the three readers, and on a 
pairwise basis (R1 versus R2, 
R1 versus R3, R2 versus R3)
a Free-marginal multirater kappa
b Cohen’s kappa
c Prevalence-adjusted bias-adjusted kappa (PABAK); HRCT, high-resolution computed tomography; 
95%CI, 95% confidence interval; R, reader; TLS, total lung score; GGO, ground-glass opacity; OP, organ-
izing pneumonia
Numbers in bold refer to R1, R2, and R3
HRCT feature Inter-reader agreement





TLS > 6 0.69 (0.56–0.82) 2 0.65 (0.47–0.83)
3 0.68 (0.50–0.85) 0.61 (0.42–0.80)
GGO > 2 0.74 (0.62–0.86) 2 0.55 (0.33–0.77)
3 0.51 (0.28–0.73) 0.78 (0.59–0.96)
Consolidation > 2 0.60 (0.46–0.74) 2 0.64 (0.45–0.83)
3 0.42 (0.20–0.64) 0.45 (0.22–0.67)
Crazy-paving pattern > 2 0.65 (0.52–0.79) 2 0.64 (0.38–0.90)c
3 0.61 (0.34–0.88)c 0.71 (0.14–1.00)c
OP pattern 0.32 (0.17–0.47) 2 0.59 (0.42–0.77)
3 0.26 (0.09–0.43) 0.29 (0.10–0.49)
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in the case of GGO > 2, crazy-paving pattern > 2, and 
TLS > 6. Of note, the latter feature was found to be an 
independent predictor of short-term onset of severe dis-
ease at multivariable analysis, regardless of readers’ expe-
rience. When considering experienced readers only, severe 
disease was independently predicted also by OP pattern (in 
the case of R1), and consolidation > 2 (in the case of R2), 
in accordance with higher pairwise agreement on those 
two features (k = 0.59 and 0.64, respectively). Our findings 
are in line with previous studies showing substantial-to-
almost perfect inter-reader agreement for most CT features 
[14, 16], and the capability of semi-quantitative or quan-
titative evaluation of lung involvement [10, 12] to predict 
disease worsening. Overall, our results provide reliable 
potential markers for disease progression.
Concerning the estimation of COVID-19 pneumonia 
extent, Cozzi et al. recently proposed a quantitative method 
based on chest X-ray performed in an emergency setting, 
correlating with an increased risk of admission to ICU [29]. 
In parallel, a few Authors [11–14] evaluated lung involve-
ment from COVID-19 pneumonia under the form of CT 
severity score [14], CT score [11], total lung involvement 
[13], and, conversely, total extent of well aerated lung paren-
chyma [12]. Computerized aided methods for the quantifica-
tion of lung involvement in COVID-19 pneumonia were also 
investigated [30]. We used TLS for this purpose. This makes 
our results difficult to compare, though our approach shows 
the potential advantage of accounting for different HRCT 
manifestations when quantify pulmonary involvement. Of 
note, we found this parameter to be reliable, showing sub-
stantial inter-reader agreement for a cutoff >6, regardless of 
readers’ experience in thoracic imaging. One can assume 
this is a potentially relevant result, since non-thoracic radi-
ologists can be involved in reporting in the pandemic-related 
scenario. Since TLS was an independent predictor of clinical 
worsening, a reliable quantification of this feature, even by 
non-thoracic radiologists, might impact on patients’ manage-
ment (e.g., in terms of patients’ allocation in ICU).
Concerning other HRCT features, Zhang et al. [16] found 
excellent inter-reader agreement in assessing consolidation 
(k = 0.983) and crazy-paving pattern (k = 0.978) between 
experienced readers. Differently from them, we observed 
lower (even if substantial) agreement. A potential explana-
tion for the discrepancy might be related to the fact that our 
assessment included not only the presence but also the extent 
of those HRCT features. While this can expectedly lead to 
lower agreement, our approach has the potential advantage 
of adding a semi-quantitative evaluation of the amount of 
lung involvement.
The OP pattern is part of typical COVID-19 pneumonia 
appearance (type 1 category), according to the RSNA cat-
egorization system [7], as well as a marker of other coro-
navirus-related lung diseases [i.e., severe acute respiratory 
syndrome (SARS), and Middle East respiratory syndrome 
(MERS)] [31, 32]. Consolidation has been identified as a 
potential marker of disease progression, reflecting cellular 
fibromyxoid exudates in alveoli [33, 34]. When analyzing 
readings from more experienced readers, both features were 
significantly associated to severe disease on univariable 
analysis (R1 and R2), with OP pattern and consolidation > 2 
representing an independent predictor of the outcome for R1 
and R2, respectively. However, k values for those features 
were disappointing, both overall and when comparing R1 
or R2 versus R3. On the other hand, the agreement rose 
when comparing R1 and R2. Those results suggest that OP 
pattern and consolidation are more reliable and can repre-
sent markers for clinical evolution only when provided by 
experienced readers.
In the case of OP pattern, this may be due to its com-
posite definition, which includes many HRCT findings at 
Table 3  Results from the 
logistic regression model 
(outcome, development of 
severe disease within 15 days 
from HRCT)
Note: OR, odds ratio; 95%CI, 95% confidence interval; R1, reader 1; R2, reader 2; R3, reader 3; TLS, total 
lung score; OP, organizing pneumonia
Numbers in italic refer to p values when statistically significant
Variable Univariable analysis, p Multivariable analysis
OR (95%CI), p
R1 R2 R3 R1 R2 R3












Crazy-paving pattern > 2 0.955 0.959 0.680 – – –
OP pattern <0.001 0.001 0.303 6 (1.35–26.64), 0.019 – –
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a time [21]. As supported by the lower prevalence in R3 
readings, the OP pattern was presumably more difficult to 
assess by less experienced readers. Our results concerning 
consolidation can be explained by the expectedly lower 
accuracy to assess the extent of this otherwise easier to 
interpret finding.
Some study limitations warrant mention. First, this is a 
monocentric work, suggesting that our findings should be 
validated by multi-institutional trials. However, our results 
are overall in line with previous works performed both in 
Western [12] and in Eastern [10, 11] scenarios of the pan-
demic, suggesting they are reasonably generalizable. Sec-
ond, we limited our models to imaging findings, excluding 
patients’ comorbidities and other clinical factors. On the 
other hand, the definition of clinically predictive models was 
beyond the purpose of the study. We focused on inter-reader 
agreement assuming that, in an emergency scenario, reliable 
imaging findings can represent more objective data for man-
aging patients with known mild COVID-19 pneumonia than 
clinical features that can be incompletely known at the time 
of HRCT. Finally, we did not include the whole spectrum 
of HRCT features in the analysis. This choice was done to 
avoid asking the less experience reader to interpret subtler 
findings, for which the agreement would be expectedly low.
In conclusion, we observed that, regardless of radiolo-
gists’ experience in chest imaging, there was moderate-to-
substantial agreement for most HRCT features of COVID-19 
pneumonia, in terms of semi-quantitative assessment of lung 
involvement. Some of the features were predictive for short-
term evolution to severe disease, namely: (i) TLS > 6, show-
ing substantial inter-reader agreement regardless of read-
ers’ experience; (ii) consolidation > 2 and OP pattern, which 
showed acceptable inter-reader agreement between more 
experienced readers only. Thus, the agreement on different 
HRCT features apparently depends on readers’ experience.
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